Literature DB >> 9832045

A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.

E S Moreira1, M Vainzof, S K Marie, V Nigro, M Zatz, M R Passos-Bueno.   

Abstract

Among the heterogeneous group of autosomal recessive limb-girdle muscular dystrophies (AR LGMDs), the sarcoglycanopathies (LGMD2C-2F) represent a subgroup characterised by defects in the gamma, alpha, beta, and delta sarcoglycan genes, respectively. Genotype-phenotype correlations in these forms of AR LGMD are important to enhance our understanding of protein function. Regarding LGMD2F, only two homozygous frameshift mutations have been reported to date in patients with a severe phenotype. In the present report, through screening 23 unrelated AR LGMD patients, we identified three subjects with LGMD2F, two with a previously reported frameshift mutation and the other homozygous for a new missense mutation in the delta sarcoglycan gene. Interestingly, this new mutation is also associated with a severe clinical course. In addition, our results suggest that this form of severe AR LGMD is not very rare in our population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832045      PMCID: PMC1051491          DOI: 10.1136/jmg.35.11.951

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  23 in total

1.  Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD.

Authors:  M R Passos-Bueno; E S Moreira; M Vainzof; S K Marie; M Zatz
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

2.  Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D).

Authors:  A Carrié; F Piccolo; F Leturcq; C de Toma; K Azibi; C Beldjord; J M Vallat; L Merlini; T Voit; C Sewry; J A Urtizberea; N Romero; F M Tomé; M Fardeau; Y Sunada; K P Campbell; J C Kaplan; M Jeanpierre
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

3.  The limb-girdle muscular dystrophies--proposal for a new nomenclature.

Authors:  K M Bushby; J S Beckmann
Journal:  Neuromuscul Disord       Date:  1995-07       Impact factor: 4.296

Review 4.  Muscular dystrophies: diseases of the dystrophin-glycoprotein complex.

Authors:  R Worton
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

5.  Evidence for linkage disequilibrium in chromosome 13-linked Duchenne-like muscular dystrophy (LGMD2C)

Authors:  K Ben Othmane; M C Speer; J Stauffer; S Blel; L Middleton; C Ben Hamida; A Etribi; D Loeb; F Hentati; A D Roses
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

6.  Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses.

Authors:  D G Monckton; L J Wong; T Ashizawa; C T Caskey
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

Review 7.  Dystrophin-associated proteins in muscular dystrophy.

Authors:  E Ozawa; M Yoshida; A Suzuki; Y Mizuno; Y Hagiwara; S Noguchi
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

8.  Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.

Authors:  L E Lim; F Duclos; O Broux; N Bourg; Y Sunada; V Allamand; J Meyer; I Richard; C Moomaw; C Slaughter
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

9.  Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy.

Authors:  S Noguchi; E M McNally; K Ben Othmane; Y Hagiwara; Y Mizuno; M Yoshida; H Yamamoto; C G Bönnemann; E Gussoni; P H Denton; T Kyriakides; L Middleton; F Hentati; M Ben Hamida; I Nonaka; J M Vance; L M Kunkel; E Ozawa
Journal:  Science       Date:  1995-11-03       Impact factor: 47.728

10.  Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex.

Authors:  C G Bönnemann; R Modi; S Noguchi; Y Mizuno; M Yoshida; E Gussoni; E M McNally; D J Duggan; C Angelini; E P Hoffman
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

View more
  8 in total

1.  Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy.

Authors:  Ida Luisa Rotundo; Stefania Faraso; Elvira De Leonibus; Gerardo Nigro; Carmen Vitiello; Alessio Lancioni; Daniele Di Napoli; Sigismondo Castaldo; Vincenzo Russo; Fabio Russo; Giulio Piluso; Alberto Auricchio; Vincenzo Nigro
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

2.  Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.

Authors:  R D Cohn; M Durbeej; S A Moore; R Coral-Vazquez; S Prouty; K P Campbell
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

Authors:  S Tsubata; K R Bowles; M Vatta; C Zintz; J Titus; L Muhonen; N E Bowles; J A Towbin
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy.

Authors:  Satu Kärkkäinen; Raija Miettinen; Petri Tuomainen; Päivi Kärkkäinen; Tiina Heliö; Eeva Reissell; Maija Kaartinen; Lauri Toivonen; Markku S Nieminen; Johanna Kuusisto; Markku Laakso; Keijo Peuhkurinen
Journal:  J Mol Med (Berl)       Date:  2003-10-15       Impact factor: 4.599

5.  A Haplotype of Two Novel Polymorphisms in δ-Sarcoglycan Gene Increases Risk of Dilated Cardiomyopathy in Mongoloid Population.

Authors:  Jie Chen; Ye Jin; Hong Wang; Sisi Wei; Dan Chen; Li Ying; Qing Zhou; Gang Li; Joyce Li; Jimin Gao; Naoya Kato; Wei Hu; Yigang Li; Yuepeng Wang
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

6.  Exome sequencing reveals independent SGCD deletions causing limb girdle muscular dystrophy in Boston terriers.

Authors:  Melissa L Cox; Jacquelyn M Evans; Alexander G Davis; Ling T Guo; Jennifer R Levy; Alison N Starr-Moss; Elina Salmela; Marjo K Hytönen; Hannes Lohi; Kevin P Campbell; Leigh Anne Clark; G Diane Shelton
Journal:  Skelet Muscle       Date:  2017-07-11       Impact factor: 4.912

7.  Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach.

Authors:  Araba A Adjei; Camden L Lopez; Daniel J Schaid; Jeff A Sloan; Jennifer G Le-Rademacher; Charles L Loprinzi; Aaron D Norman; Janet E Olson; Fergus J Couch; Andreas S Beutler; Celine M Vachon; Kathryn J Ruddy
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

Review 8.  A Journey with LGMD: From Protein Abnormalities to Patient Impact.

Authors:  Dimitra G Georganopoulou; Vasilis G Moisiadis; Firhan A Malik; Ali Mohajer; Tanya M Dashevsky; Shirley T Wuu; Chih-Kao Hu
Journal:  Protein J       Date:  2021-06-10       Impact factor: 2.371

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.